Ignite Creation Date:
2025-12-24 @ 7:43 PM
Ignite Modification Date:
2026-05-24 @ 9:43 AM
Study NCT ID:
NCT00058903
Status:
COMPLETED
Last Update Posted:
2010-01-13
First Post:
2003-04-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Treatment of Cholestatic Pruritus With Sertraline
Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Organization:
Study Overview
Official Title:
Treatment of Cholestatic Pruritus With Sertraline
Status:
COMPLETED
Status Verified Date:
2010-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this study is to find an effective and well-tolerated medical therapy for itching due to liver disease. Persons with primary biliary cirrhosis or chronic hepatitis C are currently being enrolled in the study. Persons participating in the study are given sertraline, a medication which is also often used for depression,to treat their itching. The dose is gradually increased as the effect on itching and any other potential side effects are carefully monitored.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: